nach oben

Rheumatology International

Erschienen in:

01.05.2009 | Letter to the Editor

A proposed model for effective collaboration between rheumatologists and clinical pathologists for the diagnosis of autoimmune rheumatic diseases

verfasst von: Nicola Bizzaro, Gabriella Morozzi

Erschienen in: Rheumatology International | Ausgabe 7/2009

Einloggen, um Zugang zu erhalten

Excerpt

Tests for detecting autoantibodies are very useful in diagnosing and monitoring autoimmune rheumatic diseases (ARD). However, the continual discovery of new specific autoantibodies and the great advances in laboratory technology have given rise in recent years to the introduction of new tests and new diagnostic methods to the point that the clinician may find himself in difficulty as to which tests should be requested in a given context and how the results obtained should be interpreted. …

Sherer Y, Gorstein A, Fritzler MJ, Shoenfeld Y (2004) Autoantibody explosion in systemic lupus erythematosus. Semin Arthritis Rheum 34:501–537. doi:10.1016/j.semarthrit.2004.07.002 PubMedCrossRef

Arbuckle MR, Mc Clain MT, Rubertone MV, Scofield RH, Dennis GJ, James JA et al (2003) Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 349:1526–1533. doi:10.1056/NEJMoa021933 PubMedCrossRef

Bizzaro N (2007) Autoantibodies as predictors of disease: the clinical and experimental evidence. Autoimmun Rev 6:325–333. doi:10.1016/j.autrev.2007.01.006 PubMedCrossRef

Wiik AS, Gordon TP, Kavanaugh AF, Lahita RG, Reeves W, van Venrooij WJ et al (2004) Cutting edge diagnostics in rheumatology: on the role of patients, clinicians, and laboratory scientists in optimizing the use of autoimmune serology. Arthritis Care Res 51:291–298. doi:10.1002/art.20229 CrossRef

Kavanaugh AF, Tomar R, Reveille J, Solomon DH, Homburger HA (2000) Guidelines for clinical use of the antinuclear antibody test and tests for specific autoantibodies to nuclear antigens. Arch Pathol Lab Med 124:71–81PubMed

Kavanaugh A (2001) The utility of immunologic laboratory tests in patients with rheumatic diseases. Arthritis Rheum 44:2221–2223. doi:10.1002/1529-0131(200110)44:10<2221::AID-ART383>3.0.CO;2-T

Solomon DH, Kavanaugh AJ, Schur PH (2002) and the American College of Rheumatology ad Hoc Committee on Immunologic Testing Guidelines. Evidence-based guidelines for the use of immunologic tests: antinuclear antibody testing. Arthritis Rheum 47:434–444. doi:10.1002/art.10561 PubMedCrossRef

Kavanaugh AF, Solomon DH (2002) and the American College of Rheumatology ad Hoc Committee on Immunologic Testing Guidelines. Guidelines for immunologic laboratory testing in the rheumatic diseases: anti-DNA antibody tests. Arthritis Rheum 47:546–555. doi:10.1002/art.10558 PubMedCrossRef

Tozzoli R, Bizzaro N, Tonutti E, Villalta D, Bassetti D, Manoni F et al (2002) Guidelines for the laboratory use of autoantibody tests in the diagnosis and monitoring of autoimmune rheumatic diseases. Am J Clin Pathol 117:316–324. doi:10.1309/Y5VF-C3DM-L8XV-U053 PubMedCrossRef

10.

Stinton LM, Fritzler MJ (2007) A clinical approach to autoantibody testing in systemic autoimmune rheumatic disorders. Autoimmun Rev 7:77–84. doi:10.1016/j.autrev.2007.08.003 PubMedCrossRef

11.

Wiik A, Cervera R, Haass M, Kallenberg C, Khamashta M, Meroni PL et al (2006) European attempts to set guidelines for improving diagnostics of autoimmune rheumatic disorders. Lupus 15:391–396. doi:10.1191/0961203306lu2322oa PubMedCrossRef

12.

Cabana MD, Rand CS, Powe NR, Wu AW, Wilson MH, Abboud PC et al (1999) Why don’t physicians follow clinical practice guidelines? JAMA 282:1458–1465. doi:10.1001/jama.282.15.1458 PubMedCrossRef

13.

Solomon DH, Shmerling RH, Schur PH, Lew R, Fiskio J, Bates DW (1999) A computer based intervention to reduce unnecessary serologic testing. J Rheumatol 26:2578–2584PubMed

14.

Fritzler MJ, Wiik A, Fritzler ML, Barr SG (2003) The use and abuse of commercial kits used to detect autoantibodies. Arthritis Res Ther 5:192–201. doi:10.1186/ar782 PubMedCrossRef

15.

Keren DF, Nakamura RM (1997) Progress and controversies in autoimmune disease testing. Clin Lab Med 17:483–497

16.

Lock RJ (2004) Rational requesting or rationing testing? J Clin Pathol 57:121–122. doi:10.1136/jcp.2003.11122 PubMedCrossRef

17.

Homburger HA (1995) Cascade testing for autoantibodies in connective tissue diseases. Mayo Clin Proc 70:183–184PubMed

18.

Bizzaro N, Wiik A (2004) Appropriateness in anti-nuclear antibody testing: from clinical request to strategic laboratory practice. Clin Exp Rheumatol 22:349–355PubMed

19.

Wiik AS (2003) Appropriateness of autoantibody testing in clinical medicine. Clin Chim Acta 333:177–180. doi:10.1016/S0009-8981(03)00182-7 PubMedCrossRef

20.

Wiik AS (2005) Anti-nuclear autoantibodies: clinical utility for diagnosis, prognosis, monitoring, and planning of treatment strategy in systemic immunoinflammatory diseases. Scand J Rheumatol 34:260–268. doi:10.1080/03009740500202664 PubMedCrossRef

21.

Wiik A (2001) Clinical use of serological tests for ANCA: what do the studies say? Rheum Dis Clin North Am 27:799–813. doi:10.1016/S0889-857X(05)70236-2 PubMedCrossRef

22.

Tonutti E, Visentini D, Bizzaro N (2007) Interpretative comments on autoantibody tests. Autoimmun Rev 6:341–346. doi:10.1016/j.autrev.2007.01.007 PubMedCrossRef

23.

Laposata ME, Laposata M, van Cott EM, Buchmer DS, Kashalo MS, Dighe AS (2004) Physician survey of a laboratory medicine interpretative service and evaluation of the influence of interpretations on laboratory test ordering. Arch Pathol Lab Med 128:1424–1427PubMed

24.

Sinclair D, Duncan H (2004) What happens to patients with positive tissue transglutaminase and endomysium antibody results in general practice? J Clin Pathol 57:943–945. doi:10.1136/jcp.2004.016261 PubMedCrossRef

25.

Laposata M (2004) Patient-specific narrative interpretations of complex clinical laboratory evaluations: who is competent to provide them? Clin Chem 50:471–472. doi:10.1373/clinchem.2003.028951 PubMedCrossRef

26.

Plebani M (2005) The future of clinical laboratories: more testing or knowledge services? Clin Chem Lab Med 43:893–896. doi:10.1515/CCLM.2005.152 PubMedCrossRef

Titel: A proposed model for effective collaboration between rheumatologists and clinical pathologists for the diagnosis of autoimmune rheumatic diseases
verfasst von: Nicola Bizzaro
Gabriella Morozzi
Publikationsdatum: 01.05.2009
Verlag: Springer-Verlag
Erschienen in: Rheumatology International / Ausgabe 7/2009
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI: https://doi.org/10.1007/s00296-008-0783-5

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

25.04.2024 | Hypotonie | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

A proposed model for effective collaboration between rheumatologists and clinical pathologists for the diagnosis of autoimmune rheumatic diseases

Excerpt

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Update Innere Medizin

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 7/2009

Prophylactic use of lamivudine with chronic immunosuppressive therapy for rheumatologic disorders

Serum and synovial fluid leptin levels and markers of inflammation in rheumatoid arthritis

Hemolytic uremic syndrome with ischemic glomerulonephropathy and obliterative vasculopathy in a systemic sclerosis patient treated with cyclosporine-A

A modified hand anatomic index to assesss hand deformity in scleroderma

Infiltrations of plasma cells in synovium are highly associated with synovial fluid levels of APRIL in inflamed peripheral joints of rheumatoid arthritis

Genetic susceptibility to Behçet’s syndrome is associated with NRAMP1 (SLC11A1) polymorphism in Turkish patients

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Update Innere Medizin